![](https://i0.wp.com/technews.org/wp-content/uploads/2014/07/Biotech-stocks-ILMN-BIIB-AMGN-640x360.jpg?resize=640%2C360&ssl=1)
Biotech Stocks to Watch: AbbVie, Bind Therapeutics & MannKind
In the news on the Biotech Segment, we take a close look at three upcoming Biotech stocks in AbbVie, Bind Therapeutics & MannKind. Despite three rejections so far, AbbVie is reportedly still attempting to convince Shire and its major shareholders that a buyout is in their best interest. Per sources familiar with the dealings, AbbVie’s CEO Richard Gonzalez traveled to London recently to hold discreet … Continue reading Biotech Stocks to Watch: AbbVie, Bind Therapeutics & MannKind